Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS
- Status
- WITHDRAWN
- Phase
- PHASE1
First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
- Status
- RECRUITING
- Phase
- NA
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
GilteRInf 2022 Study (Gilteritinib Related Infections)
- Status
- UNKNOWN
- Phase
- N/A
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
- Status
- RECRUITING
- Phase
- N/A
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
- Status
- RECRUITING
- Phase
- NA
Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive Induction
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Allogenic NK Cells in Combination With Chemotherapy in the Treatment of r/r AML After Allo-HSCT
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Status
- RECRUITING
- Phase
- PHASE1
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1